Literature DB >> 28780977

Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18.

Angeliki Melidou1, Eeva Broberg2.   

Abstract

During the European 2016/17 influenza season, A(H3N2) viruses have predominated and the majority clustered in genetic subclade 3C.2a1. Genetic analyses showed that circulating viruses have undergone considerable genetic diversification of the haemagglutinin gene from the current vaccine virus A/Hong Kong/4801/2014 (clade 3C.2a), but the antigenic data that is limited by the challenges with the antigenic characterisation of currently circulating A(H3N2) viruses, showed no clear evidence of antigenic change. The recommended A(H3N2) vaccine component for the northern hemisphere 2017/18 influenza season remained unchanged. However, early and mid-season vaccine effectiveness (VE) estimates were suggestive of reduced VE against A(H3N2) viruses.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  A(H3N2); Amino acid substitution; Emergence; Europe; Influenza virus; Season; Surveillance

Mesh：

Substances：

Year:  2017        PMID： 28780977     DOI： 10.1016/j.vaccine.2017.07.057

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  9 in total

1.  Influenza Vaccine Effectiveness Against Influenza A(H3N2) Hospitalizations in Children in Hong Kong in a Prolonged Season, 2016/2017.

Authors:  Susan S Chiu; Mike Y W Kwan; Shuo Feng; Joshua S C Wong; Chi-Wai Leung; Eunice L Y Chan; Kwok-Hung Chan; Tak-Keung Ng; Wing-Kin To; Benjamin J Cowling; J S Malik Peiris
Journal:  J Infect Dis       Date:  2018-04-11       Impact factor: 5.226

2.  Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season.

Authors:  Marc Rondy; Alin Gherasim; Itziar Casado; Odile Launay; Caterina Rizzo; Daniela Pitigoi; Aukse Mickiene; Sierk D Marbus; Ausenda Machado; Ritva K Syrjänen; Iva Pem-Novose; Judith Krisztina Horváth; Amparo Larrauri; Jesús Castilla; Philippe Vanhems; Valeria Alfonsi; Alina E Ivanciuc; Monika Kuliese; Rianne van Gageldonk-Lafeber; Veronica Gomez; Niina Ikonen; Zvjezdana Lovric; Annamária Ferenczi; Alain Moren
Journal:  Euro Surveill       Date:  2017-10

3.  Influenza A(H3N2) virus variants and patient characteristics during a summer influenza epidemic in Taiwan, 2017.

Authors:  Tsung-Pei Tsou; Chia-Ping Su; Wan-Ting Huang; Ji-Rong Yang; Ming-Tsan Liu
Journal:  Euro Surveill       Date:  2017-12

4.  Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand.

Authors:  Nungruthai Suntronwong; Sirapa Klinfueng; Preeyaporn Vichiwattana; Sumeth Korkong; Thanunrat Thongmee; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

5.  Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I-MOVE multicentre test-negative case-control study, 2011/2012-2016/2017.

Authors:  Marta Valenciano; Esther Kissling; Amparo Larrauri; Baltazar Nunes; Daniela Pitigoi; Joan O'Donnell; Annicka Reuss; Judit Krisztina Horváth; Iwona Paradowska-Stankiewicz; Caterina Rizzo; Alessandra Falchi; Isabelle Daviaud; Mia Brytting; Adam Meijer; Bernard Kaic; Alin Gherasim; Ausenda Machado; Alina Ivanciuc; Lisa Domegan; Brunhilde Schweiger; Annamária Ferenczi; Monika Korczyńska; Antonino Bella; Ana-Maria Vilcu; Anne Mosnier; Katherina Zakikhany; Marit de Lange; Sanja Kurečić Filipovićović; Kari Johansen; Alain Moren
Journal:  Influenza Other Respir Viruses       Date:  2018-05-09       Impact factor: 4.380

6.  Paediatric virology as a candidate of paediatric subspecialisation: An interview with Assistant Professor of Molecular Microbiology-Virology Angeliki Melidou.

Authors:  Ioannis N Mammas; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2018-07-31       Impact factor: 2.447

7.  Increased genetic variation of A(H3N2) virus from influenza surveillance at the end of the 2016/2017 season for Shanghai port, China.

Authors:  Zilong Zhang; Shenwei Li; Xiaolin Zhu; Jian Hou; Hong Zhang; Baihui Zhao; Zhengan Tian
Journal:  Sci Rep       Date:  2022-10-12       Impact factor: 4.996

8.  Age-Specific Seasonal Influenza Vaccine Effectiveness against Different Influenza Subtypes in the Hospitalized Population in Lithuania during the 2015-2019 Influenza Seasons.

Authors:  Monika Kuliese; Aukse Mickiene; Ligita Jancoriene; Birute Zablockiene; Giedre Gefenaite
Journal:  Vaccines (Basel)       Date:  2021-05-04

9.  Influenza vaccine effectiveness by A(H3N2) phylogenetic sub-cluster and prior vaccination history: 2016-17 and 2017-18 epidemics in Canada.

Authors:  Danuta M Skowronski; Siobhan Leir; Suzana Sabaiduc; Catharine Chambers; Macy Zou; Caren Rose; Romy Olsha; James A Dickinson; Anne-Luise Winter; Agatha Jassem; Jonathan B Gubbay; Steven J Drews; Hugues Charest; Tracy Chan; Rebecca Hickman; Nathalie Bastien; Yan Li; Mel Krajden; Gaston De Serres
Journal:  J Infect Dis       Date:  2020-03-26       Impact factor: 7.759
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.